BGI
PRAX icon

B Group Inc’s Praxis Precision Medicines PRAX Stock Holding History

B Group Inc’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.7M Hold
33,237
– – 7.94% 3
2025
Q4 		$9.8M Buy
33,237
+1,737
+6% +$323K 7.23% 5
2025
Q3 		$1.67M Sell
31,500
-3,500
-10% -$170K 1.23% 15
2025
Q2 		$1.47M Buy
35,000
+16,000
+84% +$609K 1.13% 15
2025
Q1 		$720K Buy
+19,000
New +$1.19M 0.62% 16

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

B Group Inc's PRAX Position: Q1 2026 in Review

B Group Inc held its Praxis Precision Medicines (PRAX) position steady in Q1 2026 at 33,237 shares worth $10.7M. The position accounts for 7.94% of the portfolio, ranked #3.

B Group Inc first reported a position in PRAX in Q1 2025 and has held it in 5 quarters since. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • B Group Inc held 33,237 shares of Praxis Precision Medicines worth $10.7M as of Q1 2026.
  • B Group Inc left its Praxis Precision Medicines share count unchanged in Q1 2026.
  • Praxis Precision Medicines made up 7.94% of B Group Inc's portfolio in Q1 2026, its #3 holding.
  • B Group Inc first reported a position in Praxis Precision Medicines in Q1 2025 and has held it in 5 quarters since.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on B Group Inc's 13F filing for Q1 2026, filed 15 May 2026.